Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: The double-blind placebo-controlled moscow study

[No abstract available]

Authors
Kalinchenko S.Y. 1 , Tishova Y.A. 1 , Mskhalaya G.J. 1 , Gooren L.J. 1 , Giltay E.J. 1 , Saad F. 1
Journal
Journal of Urology
Number of issue
2
Language
English
Status
Published
Link
External link
DOI
10.1016/j.juro.2010.10.029
Volume
185
Year
2011
Organizations
  • 1 Department of Endocrinology, Faculty of Medical Staff Refresher Training, People's Friendship University of Russia, Moscow, Russian Federation
Keywords
C reactive protein; cholesterol; glucose; high density lipoprotein cholesterol; insulin; interleukin 10; interleukin 1beta; interleukin 6; leptin; low density lipoprotein cholesterol; placebo; testosterone undecanoate; triacylglycerol; tumor necrosis factor alpha; adult; aged; androgen therapy; body mass; body weight; disease association; double blind procedure; drug efficacy; human; hypogonadism; inflammation; major clinical study; male; metabolic syndrome X; note; outpatient department; phase 3 clinical trial; priority journal; randomized controlled trial; Russian Federation; testosterone blood level; therapy effect; treatment duration; waist circumference
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/2589/
Share

Other records

ROLE OF PLASMIDS IN THE FORMATION OF E. COLI POLYCELLULAR FORMS

Article
Syroyeshkin A.V., Buyanova N.I., Sokolova S.L., Uspenskaya E.V., Shchipkov V.P.
Bulletin of Experimental Biology and Medicine. New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук. Vol. 150. 2011. P. 440-442